Clemente Diaz
San Juan, PRNPI 1023052719
Payments from drug & device makers
No general payments reported
No drug or device maker reported general payments to this provider for 2019–2025. That is a common and unremarkable result.
$737,056in research payments, 2019–2025
Across 96 payments — averaging $7677.66 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$269K
- Sanofi Pasteur Inc.$264K
- Merck$145K
- Takeda Pharmaceuticals U.S.A., Inc.$59K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.